Abstract
The effect of human recombinant granulocyte colony-stimulating factor (hrG-CSF) in rabbits with aortic endocarditis due to Pseudomonas aeruginosa was investigated. hrG-CSF significantly increased the number of polymorphonuclear neutrophils in blood and in cardiac vegetations and the expression of the adhesin molecule CD11b on the surface of polymorphonuclear neutrophils compared with those of animals that had not received hrG-CSF. When treatment was started 72 h after bacterial challenge, hrG-CSF alone had no antibacterial effect and did not enhance the efficacy of ciprofloxacin when used in combination, even with the higher dosing regimen used (50 micrograms/kg of body weight subcutaneously every 12 h for 4 days), in terms of number of positive blood cultures, bacterial counts in vegetations, and survival. In contrast, when treatment was started 30 min prior to bacterial challenge, hrG-CSF (50 micrograms/kg injected every 12 h) decreased bacterial titers in vegetations 72 h later (6.5 +/- 0.9 versus 7.9 +/- 0.9 log10 CFU/g of vegetation for hrG-CSF and controls, respectively; P = prophylactic administration of hrG-CSF did not increase the antibacterial effect of ciprofloxacin. We concluded that the antibacterial effect of hrG-...Continue Reading
References
Feb 1, 1975·The Journal of Pathology·D T Durack
Sep 1, 1992·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·F M WalkerM J Lewin
Jun 1, 1990·Pediatric Research·M S CairoH Modanlou
Aug 1, 1990·Infection and Immunity·H YasudaK Shimizu
Aug 1, 1990·Archives of Surgery·J C HebertR L Gamelli
Mar 1, 1991·The Journal of Infectious Diseases·E RoilidesM Rubin
Jul 18, 1991·The New England Journal of Medicine·J CrawfordG Rausch
Nov 1, 1991·The Journal of Infectious Diseases·S NelsonJ Andresen
Nov 1, 1987·Infection and Immunity·M MatsumotoT Yokota
Jun 2, 1988·The New England Journal of Medicine·J L GabriloveLawrence Souza
Jan 5, 1989·The New England Journal of Medicine·A A JakubowskiJ Gabrilove
Jan 1, 1989·Chemotherapy·A S BayerC C Nast
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·D F SahmB Clarke
Mar 26, 1988·Lancet·G MorstynR Fox
Jul 15, 1988·Annals of Internal Medicine·R I LehrerJ T Curnutte
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K WelteM A Moore
Jul 1, 1972·The American Journal of Medicine·W C Roberts, N A Buchbinder
Mar 1, 1983·Reviews of Infectious Diseases·M P Reyes, A M Lerner
Jan 1, 1982·Infection and Immunity·B R YersinL R Freedman
Jan 26, 1963·JAMA : the Journal of the American Medical Association·A A ANGRIST, M OKA
Citations
Jan 17, 2004·Lancet·Philippe Moreillon, Yok-Ai Que
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Lorna E T StearneInge C Gyssens
Feb 28, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Christian M. Schneider, Franz D. Daschner
Apr 7, 2004·The Journal of Infection·Atsushi SugiharaKyosuke Fujikawa